The Current State of Pulmonary Hypertension Evaluation and Treatment

Saturday, March 8, 2025

2:45 PM - 2:55 PM ET

Speaker(s)

Mrinalini Krishnan, MD

Regional Director, Pulmonary Hypertension
MedStar Health

Disclosure(s): Janssen Pharmaceuticals: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Liquidia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); United Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)

Disclosure(s):

Mrinalini Krishnan, MD: Janssen Pharmaceuticals: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Liquidia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); United Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)